Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$47.08 - $55.16 $21,044 - $24,656
447 Added 7.29%
6,582 $320,000
Q1 2023

May 23, 2023

BUY
$36.57 - $58.29 $224,356 - $357,609
6,135 New
6,135 $340,000
Q4 2021

Feb 14, 2022

SELL
$86.26 - $119.0 $3.8 Million - $5.24 Million
-44,069 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$100.17 - $126.36 $493,437 - $622,449
4,926 Added 12.58%
44,069 $4.91 Million
Q2 2021

Aug 17, 2021

BUY
$86.05 - $119.72 $3.37 Million - $4.69 Million
39,143 New
39,143 $4.44 Million
Q1 2021

May 18, 2021

SELL
$91.47 - $124.36 $4.57 Million - $6.22 Million
-50,000 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$66.66 - $111.74 $1.33 Million - $2.23 Million
-20,000 Reduced 28.57%
50,000 $4.98 Million
Q3 2020

Nov 13, 2020

BUY
$45.89 - $72.67 $3.21 Million - $5.09 Million
70,000 New
70,000 $5.06 Million
Q2 2019

Jul 19, 2019

SELL
$17.75 - $27.58 $1.82 Million - $2.83 Million
-102,617 Closed
0 $0
Q4 2018

Mar 08, 2019

BUY
$12.32 - $24.38 $256,674 - $507,932
20,834 Added 25.47%
102,617 $1.34 Million
Q3 2018

Oct 19, 2018

SELL
$18.82 - $28.96 $895,041 - $1.38 Million
-47,558 Reduced 36.77%
81,783 $1.81 Million
Q2 2018

Jul 25, 2018

SELL
$8.79 - $19.98 $138,301 - $314,365
-15,734 Reduced 10.85%
129,341 $2.45 Million
Q1 2018

Apr 11, 2018

BUY
$9.0 - $11.95 $477,738 - $634,329
53,082 Added 57.7%
145,075 $1.35 Million
Q3 2017

Jan 16, 2018

BUY
$8.02 - $13.33 $737,783 - $1.23 Million
91,993
91,993 $1.19 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Capital Impact Advisors, LLC Portfolio

Follow Capital Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.